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Affinity of lymphoid cells for the epidermis (epider-
motropism) is characteristic of the cutaneous T-celllym-
phomas, mycosis fungoides and the Sezary syndrome. 
Consistent with numerous studies indicating that my-
cosis fungoides is a neoplasm of OKT4+T8- ("helper/ 
inducer") T lymphocytes is the possibility that epider-
motropism is a phenotypic hallmark of this subset of 
malignant T cells. This proposal was investigated in 
mice using 8 phenotypically characterized lymphomas 
of BALB/c origin: 3 histiocytic (phagocytic, lysozyme-
positive, FeR+, lg-, Thy 1-), 1 B-cell (lgM+, FeR+, 
Thy 1-), and 4 T-cell (lg-, Thy 1+) lines, including 1 
with markers of mouse helper/inducer T cells 
(Lytl +23-), 2 with suppressor/cytotoxic markers 
(Lytl -23+) , and 1 with markers of immature thymo-
cytes (Lyt1+23+). The intracutaneous growth pattern 
of these lines was studied on hematoxylin and eosin-
stained sections through the centers of tumors obtained 
at times after intradermal injection into parallel groups 
of syngeneic mice. All of these lymphomas manifested 
variable epidermotropism that followed a typical se-
quence. Following dermal growth and spread to the 
dermal-epidermal junction, tumor cells appeared within 
the stratum spinosum. Subsequently, collections of cells 
appeared in spaces within the epidermis (Pautrier-like 
microabscesses) in tumors >2 em in diameter, coincident 
with early epidermal necrosis. Thus, in this animal 
model it is clear that the intraepidermal invasion/ 
gro-wth does not correlate with the helper/inducer T-cell 
surface phenotype. These observations are nonetheless 
consistent with recent studies using monoclonal antibod-
ies to cell surface antigens which have demonstrated a 
heterogeneity of lymphoid cell subsets within the epi-
dermis in lesions of mycosis fungoides and of other 
malignant and benign dermatoses. 
Mycosis fungoides and its leukemic variant, the Sezary syn-
drome, comprise the most commonly diagnosed diseases within 
the spectrum of human cutaneous T -ce ll lymphoma (CTCL). 
T hese diseases characteristically exhibi t, on histologic exami-
nation of involved skin, prominen t infiltration of the epidermis 
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by atyp ical mononuclear cells [1]. The factors t hat affect and/ 
or control this affi ni ty of lymp hoid cells for t he epidermis, 
which is known as epidermotropism, are poorly understood. 
Nevertheless, its presence is of considerable value in t he his-
topathologic diagnosis of CTCL since, with t he rare exception 
of histiocytosis X (in which t he malignant cells bear t he surface 
and intracytoplasmic markers of Langerhans cells (2- 4], epi-
dermotropism is not a characteristic feature of t he skin lesions 
in other ma lignant lymphomas/ leukemias [5-10] . 
It is widely recognized that the malignant T cells in the blood 
of patients with Sezary syndrome [11) and those in t he extra-
cutaneous tumors and involved lymph nodes of patients with 
mycosis fungoides or Sezary syndrome [1 2,13] can act as pure 
populations of "helper/ inducer" cells, i.e., they can augment 
significant ly t he production of an t ibody by mitogen-st imulated 
normal B cells. Furthermore, many studies have shown that 
the atypical cells in both extracutaneous and cutaneous sites 
[14- 21], as well as virtually all of t he atypical cells within the 
epidermis [18- 21], express cell surface antiaens characteristic 
of normal helper/ inducer T cells (i.e., recog;ized by t he OKT4 
monoclonal antibody), but do not bear the OKT8 an tiaen 
characteristic of normal T ce lls with suppressor/cytotox ic "ac-
tivity. Such evidence suggests that epidermotrop ism may be 
another phenotypic hallmark of this discrete subset of T4+T8-
malignant helper/ inducer T cells. 
There are no documented examples of murine lymphomas in 
which spontaneous cutaneous lesions develop. However, a sub-
stant ial number of transplantable mouse lymphomas have been 
characterized previously for t heir expression of distinctive T 
cell, B cell, and macrophage/ monocyte cell surface markers 
[22,23]. These lymphomas were known to grow to la rge tumor 
nodules when injected into the skin (B. Mathieson, unpublished 
observat ions) ; however, no histopathologic studies had been 
carried out with the intent of determining which , if any, of the 
lymphomas had the capacity to invade/grow within the over-
lying epidermis. Thus, the purpose of the present study was to 
test the hypothesis that, fo llowing intradermal inoculation into 
normal syngeneic mice, the capacity to invade t he epidermis is 
a characteristic of malignant T cells with a helper/inducer 
phenotype but not of other malignant T or non-T cells. An 
abstracted report of these studies has been published (24]. 
MATERIALS AND METHODS 
Animals 
Female BALB/c mice were obtained from Cu mberland View Farmg, 
Inc., Clinton, Tennessee, and were used at 8-16 weeks of age. 
Ly mphomas 
Eight different BALB/c lymphoma lines were obtained from the 
Li tton Bionetics, Inc., Tumor Bank (Kensington, Maryland) (Dr. Mi -
chael Potter, National Cancer Institute Project Officer). The pheno-
typic characterization of each of these lines, which arose either spon-
taneously or after priming with estrogen or ethylni trosourea (ENU), is 
summarized in Table L 
Three histiocytic lines, designated Histio 101, 201, and 202, were 
characteri zed by Dr. Peter Ralph, Sloan Kettering Institute (unpub-
lished observations), as being phagocytic tumors which synthetize 
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lg-, T hy 1-, FeR+, lysozyme+, 
phagocytic 
lgM+, FeR+, Thy 1-
lg-, Thy 1+, Ly 1-23+ 
lg- , Thy 1+, Ly 1+23-
lg-, Thy 1+, Ly 1+23+ 
lysozyome and have ce ll surface Fe receptors (FeR+), but lack both the 
cell surface immunoglobuli n characteristic of B cells (lg-) and the Thy 
l marker cha racte ristic of murine T cells (Thy 1-). The B cell line, 
BALTNLM 17, has been defined by t he presence of cell surface lgM 
(TgM+) and Fe receptors, and the absence of Thy 1 [22]. Finally, 4 T-
cell tumors, each lg- and Thy 1 + , also have been characterized previ-
ously by the presence or absence of the Lyt antigens known to be 
differentia lly expressed on discrete subpopulations of murine T cells 
[23]: LUT 13 is Lyt 1 +23- (phenotypica lly equivalent. to human 
T4+T8- helper/induce r T cells); BALENTL 5 and LUT 14 are Lyt 
1-23+ (equivalent to human T4-T8+ supressor/cytotox ic T cells); 
and Pl798 is Lyt 1 + 23+ (equ ivalent to human T4+T8+ "immature" 
thymocytes). 
The tumors were each maintain ed as ascites lines by serial i.p. 
passage every 10- 18 days of 5 x 106 viable cells in BALB/c recipients 
primed 2-3 weeks earlier by an i.p. injection of 0.4 ml of Pristane 
(2 ,6,10,14-tetramethylpentadecane, Aldrich Chemical Co. , Milwaukee, 
Wisconsin). 
Experimental Protocol 
Single cell suspensions of the tumor cell lines were obtai ned by 
collecting the cell -rich ascit ic fluid in Hanks' balanced salt solution 
(HBSS, Gibco, Grand Island, New York). After washing 3 times, each 
cell line was resuspended in HBS to a concentration of 100 X 106 
viable cells/ml (determ ined by trypan blue dye exclusion). Groups of 
3- 5 normal BALB/c mice were than injected intradermally with 5 x 
106 ce lls (0.05 ml) from one of the suspensions using a syringe equipped 
with a 30-gauge needle. Each lymphoma was injected similarly into 
panels of norm al rec ipient mice on at least. one other occasion; thus, 
each tumor line was inoculated in to 6- 19 recipients (see Results) . At 
var ious times after inoculation, mice in each of the groups were sacri-
!iced, the tumor diameters were measured, and the tumors excised with 
a 2- 3 mm margin of clinically uninvolved skin. A 3- to 5-mm sect ion 
extending from the ma rgins and through the center of the tumor was 
removed from each and fixed in 10% neutral buffered form alin . Par-
affin-em bedded sections (7 I'm) were stained with hematoxylin and 
eosin and then exa mined by standard bright-field microscopy. The 
specimens had been prev iously coded so t hat the histopathologic eval-
uation conducted by one of us (M.P.) would be ca rried out without 
prior know ledge of either the specific tumor being examined or t he 
number of days after inoculation that it had been removed. The 
fo ll owing histopathologic features were recorded: the presence of a 
subepidermal zone uninvolved by tumor (grenz zone); infil tration of 
the ep idermis by sin gle lymphoma cells (single cell epidermotropism); 
t.he prese nce of lymphoma cells in clusters in lucent spaces within 
non necrotic epidermis (Pautrier-like microabscesses); and the presence 
of coagulation necrosis of the epidermi s. 
RESULTS 
Fig 1 illustrates the growth rates of the 8 lymphomas, ex-
pressed as tumor diameter (maximal dimension in mm) vs day 
after inoculation. The least-squares linear r egress ion lines are 
depicted without t he scattergram points; however, each line 
was calcu lated from a minimum of 6 data points. The 3 histio-
cytic lymphomas were, as a group, the fastest-growing tumors 
(Fig 1A ); the remaining T- and B -celllymphomas had compa-
rable growth rates, with the exception of the T lymphoma, 
LUT 14, which was a s lightly more rapidly growing tumor (Fig 
lB). 
Microscopically, a typical chronologie sequence of intracu-
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FIG 1. In tracutaneous growth rates of t he 8 lymphoma lines. The 
least-squares linear regression lines derived from scattergram points 
(not shown) a re depicted for the 3 histiocytic lines (A) and for the B 
and T cell lymphomas (B) . The number of data points ranged from 6 
(Histio 101) to 19 (BALENTL 5). Histio 101, Histio 201, and LUT 14 
were t he most rapidly growing tumors. 
taneous growth was found for all of t he lymphomas, irrespective 
of their cell surface phenotype. This began as tumor growth 
within t he dermis and subcutis but with init ial sparing of the 
immediate subepidermal area (grenz zone) (Fig 2A ). Infre-
quently, at this stage, occasional s ingle lymphoma cells could 
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be found within the epidermis (single cell epidermotropism 
with preserved grenz zone). This did not appear to correlate 
with any specific tumor phenotype. More commonly, the tu-
mors subsequently grew to t he epidermal-dermal interface (Fig 
2B), followed by the development of single cell epidermotrop-
ism (Fig 2C) with or without the presence of epidermal edema 
(spongiosis). Thereafter, collections of lymphoid cells within 
intraepidermal lucent spaces, resembling Pautrier's microab-
scesses, appeared (Fig 2D). Concurrently, foci of epidermal 
coagulation necrosis developed, eventuating in complete ulcer-
ation of t he epidermis overlying the tumors. The minimum 
tumor sizes, averaged for all 8 lymphomas for loss of grenz 
zone, appearance of single cell epidermotropism, development 
of Pautrier- like miocroabscesses, and necrosis ofthe epidermis, 
were 14.4, 16.6, 19.5, and 18.9 mm, respectively. 
Fig 3 displays the mean diameter (plus 1 SD) of tumors 
having each of the 4 histologic endpoints. The data demonstrate 
the typical chronologie sequence noted with all of the lympho-
mas: for tumors with loss of the grenz zone, the mean tumor 
diameter was 21.2 mm; for single cell epidermotropism, 21.9 
mm; for Pautrier-like microabscesses, 23.2 mm; and for epider-
mal necrosis, 22.5 mm. Compared wit h LUT 14 and Histio 101 
and 201, the lymphomas Histio 202 and P1798 had a significant 
t endency for loss of grenz zone and appearance of single cell 
epidermotropism at a smaller tumor diameter (p < 0.02 and p 
< 0.05, respectively, by the t-test for independent means) . No 
s ignificant differences in mean tumor diameter were found 
among the 8 tumor lines with respect to appearance of Pautrier-
like microabscesses and ep idermal necrosis. 
DISCUSSION 
The present study was stimulated by the possibility that 
inherent differences exist in the ability of phenotypically dis-
t inctive neoplastic lymphoid cells to invade t he epidermis. This 
hypothesis was based in part upon the prominent epidermo-
t ropism that is characteristic of the human disease spectrum 
of CTCL [1] . A large number of studies have examined the 
phenotype of the neoplastic lymphoid cells in mycosis fun-
goides/Sezary syndrome, either in functional assays or by the 
use of monoclonal antibodies to identify specific cell surface 
FIG 2. Histologic chronology of in-
t racutaneous growth of murine lympho-
mas. Photomicrographs are from 
BAL TNLM 17 tumors and depict intra-
derma l tumor growth with initial grenz 
zone (A), growth of tumor to dermal-
epidermal interface (8), presence of sin-
gle cell epidermotropism (C), and devel-
opment of Pautrier-like microabscesses 
(D ). (Paraffin-embedded 7-}.lm sections, 
H&E stained, original magnifications x 
250- 400.) 
A 
markers. These studies have consistently demonstrated that 
the malignant cells in the skin and extracutaneous sites have 
not only the functional [11-13] but also the cell surface phen-
otypic [14- 21] characteristics of normal helper/ inducer T cells. 
In addition, severa l studies have reported that the phenotype 
of the overwhelming majority of cells infiltrating the epidermis 
of lesional skin is T4+T8- [18-21]. In contrast, cutaneous 
lesions are also frequently observed in patients with adult T-
cell lymphoma/leukemia (ATL); however, epidermotropism is 
variable, but in general is less consistently a prominent histo-
pathologic feature of these lesions [25,26]. Furthermore, func-
tional studies of the malignant cells in ATL have repeatedly 
shown that these cell s act to suppress (and not help) other B-
and T-cell responses (27,28], and in at least one such case the 
leukemic cells had the phenotype of normal suppressor/ cyto-
toxic T cells (i.e., T4-T8+) [14]. Similarly, Vander Putte and 
coworkers have very recently described several patients with 
an unusual T-cell lymphoma in whom the skin lesions dem-
onstrated a complete lack of epidermotropism and whose ma-
lignant T cells were phenotypically similar to immature thy-
mocytes [29,30]. Finally, epidermal invasion in lesions of cu-
taneous lymphomas of non-T-cell origin is distinctly unusual 
[5- 10], with the rare exception of the Langerhans-like cell 
comprising the neoplastic inJiltrate in histiocytosis X (2- 4] . 
The above considerations prompted us to consider that: (1) 
there are inherent differences in the affinities of neoplastic 
helper/inducer T cells vs neoplastic suppressor/ cytotoxic T 
cells and non-T-lymphoid cells for normal epidermis, and/ or 
(2) there are other local factors peculiar to lesional skin in 
cases of epidermotropic CTCL that are responsible for the 
characteristic epidermal invasion/growth. We therefore tested 
the first possibility, i.e., that inherent differences exist between 
malignant lymphomas with respect to their capacity to migrate 
into normal epidermis, by studying histologically the intracu-
taneous growth in syngeneic mice of a number of transplantable 
BALB/ c lymphomas of known phenotype. This animal model 
obvio~sly imperfectly represents the human diseases of mycosis 
fungo1des/Sezary syndrome because the neoplastic cells do not 
migrate into the skin spontaneously but only grow intracuta-
neously followi ng direct inoculation. Nonetheless, there was no 
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FIG 3. Mean diameter of tumors having each of 4 histologic end-
points. T he bar graphs in each panel depict the mean diameter ( + 1 SD) 
of those lumors of a given lymphoma line having the indicated histo-
logic featu re. Each of t he 8 lymphomas developed epidermal invasion 
during intracuta neous growth, a lt hough t here were minor but statisti-
cally significant differences among some of t he lymphomas in t he mean 
tumor diamete rs to loss of grenz zone and presence of single cell 
epidermotropism (see text). The number of tumors evaluated histolog-
ically ranged from 6 (H istio 101) to 19 (BALENTL 5). 
a priori reason to expect t hat such a model could not iden t ify 
sign ifica nt diffe rences in the affin ities of malignant cells fo r 
the epidermis during the course of int racutaneous growth, if 
such differences were inherent properties of t he malignant cells. 
We fou nd t hat 1 B cell , 4 T cell (1 with helper/inducer, 2 
with suppressor/cytototoxic, and 1 with immature thymocyte 
markers), and 3 histiocytic lymphomas each displayed epider-
motropism during intracutaneous growth wit h essent ially equal 
faci li ty. T he invasion of ep idermis by the tumor cells occurred 
as part of a typical chronologie sequence beginning as growth 
of t he tumor to the dermal-epidermal junction. Subsequent ly, 
individual tumor cells invaded between the keratinocytes. Fi-
nally, coincident wit h epidermal necrosis, collections of tumor 
cells appeared in lucent spaces within the epidermis in a pattern 
indistinguishable from t he classical Pautrier's microabscesses 
of mycosis fungoides (Fig 2). 
We conclude that in this particular murine model, epider-
motropism is not an exclusive property of malignant T cells 
with a helper/inducer phenotype, but rather can be displayed 
by malignant cells from all t he major lymphoid populations. 
T his conclusion is tempered by t he realization t hat only one 
BALB/c T-cell lymhoma with the helper/inducer phenotype (Lyt 1 +23-) has been ident ified and was t herefore available 
for study; t he possibili ty that other Lyt 1 +23- lines, if studied 
in the same way, would display significan tly earlier and/or 
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greater epidermotropism t han t he other lines should be kept in 
mind. In other words, it is conceivable t hat early epidermal 
invasion/growth is indeed particularly characteristic of some 
malignant helper/ inducer T cells, but that the one analyzed in 
thi s study had lost that special fac ili ty to t he point that its 
pattern of growth became indistinguishable from the other 
lymphomas tested. Such a loss of usually characteristic markers 
during t he clinical course of CTCL in humans has been well 
documented to be common, both with respect to cell surface 
markers [13) and the tendency to display epidermotropism 
[31,32]. 
Nevert heless, our resul ts suggest that there may not be 
inherent differences in t he abilit ies of neoplastic helper/inducer 
T cells vs suppressor/cyotoxic T cells, immature thymocytes, 
B cells, and histiocytes to invade and grow wit hin normal 
epidermis. On t he cont rary, our studies imply that other factors 
and/or cellular interactions operate wit hin lesional skin to 
induce epidermotropism of the malignant cells. A potent ial role 
for skin -specific soluble facto rs has been suggested by very 
recent in vit ro studies in which migration of Sezary syndrome, 
but not normal, peripheral blood lymphocytes toward skin, but 
not muscle, explants was demonstrated [33). The existence of 
such factors and/or alterations in immunoregulatory cellular 
in teractions (such as those involving T cells and Langerhans 
cells) has been hypothesized repeatedly [34- 38]. One such 
hypothesis suggests t hat epidermotropic helper/inducer T cells 
in fact represent t he malignant expansion of cells with specific 
receptors for ant igens abnormally expressed within lesional 
epidermis [35-38]. 
Finally, of relevant interest to t he present demonstration of 
the apparent nonspecificity of ep idermotrop ism for particular 
malignant lymphomas are recent data concerning t he in situ 
polymorphism of lymphoid ce ll subsets in the epidermis of 
lesions of classic CTCL and other cutaneous lymphomas, as 
well as other inflammatory dermatoses . Thomas et al [39] have 
reported that the epidermis of earl y lesions of mycosis fungoides 
is infiltrated preferent ially by T4-T8+ suppressor/cytotoxic T 
cells, while Willemze and coworkers (40] observed both 
T4+T 8- and T 4-T8+ subsets in the epidermis of biopsies 
from CTCL patients. Caputo eta! (41] have recently reported 
a case of verrucoid epidermotropic T -cell lymphoma (perhaps 
a variant of Pagetoid reticulosis) in which the overwhelming 
majority of the ab normal int raepidermal T cells were T4-T8+. 
T he capacity of atypical cells with markers characteristic of 
histiocytes to infil trate the epidermis in Pagetoid reticulosis 
has been documented by several investigators (42- 45], as has 
the presence of increased numbers of Langerhans cells and/or 
histiocytes in the epidermis of lesions of mycosis fungoides [19,45- 48]. 
Addit ional data analyzing t he phenotype of cells infil trating 
the epidermis of benign in fl ammatory dermatoses also suggest 
that epidemotropism is not a property only of normal helper/ 
inducer T cells. In a very recent quant itative study of nonspe-
cific migration of cells into sites of allergic contact hypersen-
sit ivity in mice, T igelaar found t hat normal Lyt 1-23+ (sup-
pressor/cytotoxic) T cells were significantly more epidermo-
t ropic t han Lyt 1+23- helper/ inducer T cells [49]. These data 
parallel t he observations that T 4- T8+ T cells were relatively 
more epidermotropic than T 4+T8- T cells in human skin 
allografts undergoing rejection [50]. 
It is clear that the facto rs governing t he capacity of both 
malignant and normal lymphoid cells to migrate from the 
dermis into the epidermis are complex and are not readily 
explicable on t he basis of a unique property of one of t he major 
phenotypically discrete subpopulations of T ce lls. Only rela-
t ively recent ly has the interaction of T cells wit h the ep idermis 
begun to receive substantial experimental attent ion (for reviews 
see (38,51]) . Further careful study of epidermal cell- lymphoid 
cell interaction is clearly needed to more fully elucidate the 
mechanisms involved in t hese interactions that characterize a 
broad spectrum of cutaneous disorders. 
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